Xavier M Keutgen
Overview
Explore the profile of Xavier M Keutgen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
774
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cozzi J, Li H, Fuhrman J, Lan L, Williams J, Finnerty B, et al.
Int J Comput Assist Radiol Surg
. 2025 Jan;
20(2):259-267.
PMID: 39751996
Purpose: Thyroid nodules are common, and ultrasound-based risk stratification using ACR's TIRADS classification is a key step in predicting nodule pathology. Determining thyroid nodule contours is necessary for the calculation...
2.
Azar S, Tobias J, Nordgren R, Kaplan E, Angelos P, Keutgen X, et al.
J Surg Res
. 2024 Dec;
305:150-155.
PMID: 39693848
Introduction: Primary hyperparathyroidism (pHPT) in children is uncommon, resulting in a paucity of data describing the disease process in this population. Herein, in an effort to bridge the information gap,...
3.
Tobias J, Azar S, Gujarathi R, Nordgren R, Vaghaiwalla T, Millis J, et al.
Surgery
. 2024 Oct;
177:108834.
PMID: 39395860
Background: With the advent of peptide receptor radionuclide therapy, the timing and sequence of surgery in the treatment of metastatic gastroenteropancreatic neuroendocrine tumors merits further study. We hypothesized that surgery...
4.
Tumati A, Marshall T, Greenspun B, Chen Z, Azar S, Keutgen X, et al.
Surgery
. 2024 Oct;
177():108833.
PMID: 39394019
Background: Integrating microRNA markers with next-generation sequencing panels may enhance risk assessment of cytologically indeterminate thyroid nodules. The ThyGeNEXT-ThyraMIRv1 multiplatform test version 1 demonstrated limited utility in risk-stratifying RAS-mutated indeterminate...
5.
Gujarathi R, Tobias J, Azar S, Keutgen X, Liao C
Cancers (Basel)
. 2024 Sep;
16(17).
PMID: 39272851
Peptide Receptor Radionuclide Therapy (PRRT), a form of Radioligand Therapy (RLT), and Capecitabine/Temozolomide (CAPTEM) are cornerstones of systemic therapy for metastatic pancreatic neuroendocrine tumors (PNETs). Data regarding comparative efficacy are...
6.
Gujarathi R, Azar S, Tobias J, Polite B, Setia N, Feinberg N, et al.
Endocr Relat Cancer
. 2024 Aug;
31(11).
PMID: 39093924
Pre-clinical data suggest that mutations in the MEN1, DAXX, and/or ATRX genes may potentially increase radiation efficacy in cancer cells. Herein, we explore the association between response to peptide receptor...
7.
Tobias J, Keutgen X
Surg Clin North Am
. 2024 Jun;
104(4):883-890.
PMID: 38944506
Pancreatic neuroendocrine tumors originate from hormone-producing islet cells and have a propensity to metastasize to the liver once they reach 2 cm in size. Their diagnosis relies upon a combination...
8.
Greenberg J, Shah Y, Ivanov N, Marshall T, Kulm S, Williams J, et al.
J Clin Endocrinol Metab
. 2024 May;
110(1):263-274.
PMID: 38817124
Context: Pancreatic neuroendocrine tumors (PNETs) exhibit a wide range of behavior from localized disease to aggressive metastasis. A comprehensive transcriptomic profile capable of differentiating between these phenotypes remains elusive. Objective:...
9.
Medullary Thyroid Cancer: Single Institute Experience Over 3 Decades and Risk Factors for Recurrence
Azar S, Tobias J, Applewhite M, Angelos P, Keutgen X
J Clin Endocrinol Metab
. 2024 Apr;
109(11):2729-2734.
PMID: 38651609
Context: Medullary thyroid cancer (MTC) has a historic recurrence rate up to 50%, and surgery remains the only cure. Objective: This study aims to assess factors related to recurrence and...
10.
Azar S, Stratton L, Memeh K, Nordgren R, Kaplan E, Angelos P, et al.
J Surg Res
. 2024 Apr;
298:88-93.
PMID: 38593602
Introduction: Elevated metanephrine and catecholamine levels 3-fold upper limit of normal (ULN) are diagnostic for pheochromocytoma. We sought to determine whether size correlates with biochemical activity or symptoms which could...